Horowitz N - Search Results

1

Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer.

Mahdi H, Gockley A, Esselen K, Marquard J, Nutter B, Yang B, Hinchcliff E, Horowitz N, Rose PG. Mahdi H, et al. Among authors: horowitz n. Gynecol Oncol. 2015 Dec;139(3):407-12. doi: 10.1016/j.ygyno.2015.07.101. Epub 2015 Jul 23. Gynecol Oncol. 2015. PMID: 26210778

2

Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé?

Horowitz NS, Tamimi HK, Goff BA, Koh WJ, Schmidt RA, Greer BE, Paley PJ. Horowitz NS, et al. Gynecol Oncol. 1999 Nov;75(2):238-41. doi: 10.1006/gyno.1999.5571. Gynecol Oncol. 1999. PMID: 10525379 Clinical Trial.

3

Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?

Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM. Cohn DE, et al. Gynecol Oncol. 2002 Dec;87(3):243-6. doi: 10.1006/gyno.2002.6825. Gynecol Oncol. 2002. PMID: 12468320

4

Adequate staging for uterine cancer can be performed through Pfannenstiel incisions.

Horowitz NS, Powell MA, Drescher CW, Smith MR, Atwood M, Mate TA, Peters WA. Horowitz NS, et al. Gynecol Oncol. 2003 Mar;88(3):404-10. doi: 10.1016/s0090-8258(02)00166-x. Gynecol Oncol. 2003. PMID: 12648594

5

The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.

Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ. Horowitz NS, et al. Gynecol Oncol. 2004 Jul;94(1):67-73. doi: 10.1016/j.ygyno.2004.03.047. Gynecol Oncol. 2004. PMID: 15262121

6

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.

Vaidya AP, Horowitz NS, Oliva E, Halpern EF, Duska LR. Vaidya AP, et al. Gynecol Oncol. 2006 Nov;103(2):684-7. doi: 10.1016/j.ygyno.2006.05.009. Epub 2006 Jun 23. Gynecol Oncol. 2006. PMID: 16797683

7

Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.

del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill CL, Horowitz N, Seiden MV. del Carmen MG, et al. Among authors: horowitz n. Gynecol Oncol. 2007 Jan;104(1):70-6. doi: 10.1016/j.ygyno.2006.07.008. Epub 2006 Sep 1. Gynecol Oncol. 2007. PMID: 16949138

8

Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.

Horowitz NS, Hua J, Powell MA, Gibb RK, Mutch DG, Herzog TJ. Horowitz NS, et al. Gynecol Oncol. 2007 Nov;107(2):344-9. doi: 10.1016/j.ygyno.2007.07.072. Epub 2007 Aug 27. Gynecol Oncol. 2007. PMID: 17720233

9

Decreased survival in EGFR gene amplified vulvar carcinoma.

Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S, Horowitz NS, Iafrate AJ, Borger DR, Rueda BR. Growdon WB, et al. Gynecol Oncol. 2008 Nov;111(2):289-97. doi: 10.1016/j.ygyno.2008.07.038. Epub 2008 Sep 3. Gynecol Oncol. 2008. PMID: 18768215

10

Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.

Matulonis UA, Krag KJ, Krasner CN, Atkinson T, Horowitz NS, Lee H, Penson RT. Matulonis UA, et al. Among authors: horowitz ns. Gynecol Oncol. 2009 Feb;112(2):394-9. doi: 10.1016/j.ygyno.2008.10.015. Epub 2008 Dec 5. Gynecol Oncol. 2009. PMID: 19058838 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

487 results

Search Page

Filters